Surprising ASX Shares Held by High-Performing Fund Managers
Delving into the portfolios of Australia's top investors unveils a selection of ASX shares that have caught their attention. While inclusion in these esteemed portfolios doesn't guarantee success, it offers valuable insights into stocks that are deemed promising by industry experts.
Image Credit: Pexels |
Aristocrat Leisure Limited (ASX: ALL)
Aristocrat Leisure stands as a prominent player in the global gaming industry, specializing in poker machines, casino management systems, and mobile games publishing. Notably, it has secured a position among the most widely-held stock picks, as indicated by leading fund managers such as DNR Capital's High Conviction Strategy. With a positive outlook for FY24, driven by anticipated growth in underlying net profit after tax (NPATA), Aristocrat Leisure is positioned for market-leading performance. The ASX share's valuation, based on Commsec estimates, reflects a favorable earnings multiple, underlining its potential for growth and value.
Goodman Group (ASX: GMG)
As a significant player in the property sector, Goodman Group holds a strong presence in industrial warehouse ownership and development. Investors are particularly drawn to its strategic focus on data centres, capitalizing on the increasing demand for artificial intelligence (AI) technology. Renowned for its Grade A industrial properties across key global markets, Goodman is viewed favorably by fund managers for its long-term growth prospects. Despite being relatively valued compared to other listed real estate investment trusts (REITs), Goodman's exposure to data centres presents promising opportunities for future expansion and innovation.
ResMed CDI (ASX: RMD)
ResMed CDI emerges as a leading healthcare share, offering digital health solutions and medical devices for sleep apnea and chronic respiratory conditions. Despite its ranking as the fifth most-held stock among high-performing funds, ResMed commands significant investor interest, notably earning the title of the most-loved stock in the ASX 20 by fund managers. Bolstered by robust financial performance, including revenue growth and improved operating margins, ResMed continues to demonstrate resilience and innovation in the healthcare sector. With optimistic sentiments from fund managers, the ASX share remains poised for sustained growth and value creation.
In conclusion, the selection of these ASX shares by top investors underscores their potential for significant upside and long-term value creation. While market dynamics and risks persist, these stocks represent compelling opportunities for investors seeking exposure to promising sectors and companies with strong growth prospects.
Comments
Post a Comment